Home
Today's Stock Newsletters
Search
Add Your Newsletter
| News from Standout Stocks12/16/2008 9:29 AM Penny Stocks by: Standout Stocks | ||||
| Stocks That Standout Newsletter ~~~~~~~~~~~~~~~~~~~~~~~~~~ main banner ~~~~~~~~~~~~~~~~~~~~~~~~~~ Issue: # 186 Dec. 16th, 2008 ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ Greetings! Quotes about Observation "In the fields of observation chance favors only the prepared mind." -Louis Pasteur "All perceiving is also thinking, all reasoning is also intuition, all observation is also invention." -Rudolf Arnheim "Nothing exists until or unless it is observed. An artist is making something exist by observing it. And his hope for other people is that they will also make it exist by observing it. I call it "creative observation." Creative viewing." -William S. Burroughs The end of the year is approaching, a new year is to be born...Let`s end this year with a bang! ~~~~~~~~~~~~~~~~~~~~~~~~~~ Today`s Breaking News UNDT Universal Detection Technology UNDT Website Finance More Important Links! US Commission Raises Alarm... Unconventional Weapons Warning... Nuke, Bioterror Attack Called Likely... Dec 16, 2008 -- Universal Detection Technology (OTCBB: UNDT) (FRANKFURT: PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats and provider of counter-terrorism consulting and training services, reported today that it has received a purchase order for its anthrax detection equipment from the city of Calgary, Canada Police Service. The purchase order comes from the department`s terrorism training division. The detection equipment is designed to check for anthrax and can return results in as little as 3 minutes. The Calgary Police Service, located in Calgary, Alberta, Canada, is made up of more than 1,600 police officers and 855 civilian members. Calgary is the largest city in the province of Alberta, Canada. The metropolitan population was 1,162,310 in 2006. A report released last week by the Commission on the Prevention of Weapons of Mass Destruction Proliferation and Terrorism says urgent security measures need to be taken soon or the world is likely to undergo an incident of terrorism using weapons of mass destruction within the next five years. "Unless the world community acts decisively and with great urgency, it is more likely than not that a weapon of mass destruction will be used in a terrorist attack somewhere in the world by the end of 2013," the report states in the opening sentence of the executive summary. The report also emphasizes the need of the new administration to prepare the nation against a future bioterrorist attack. UNDT`s anthrax detection equipment has been extensively used by first responders and private industry throughout the country. The equipment has been evaluated by the U.S. DOD as well as the United Kingdom military. The equipment`s capacities include: -- No cross-reactivity with near neighbor strains -- No cross-reactivity to household powders -- No set up time -- No expensive reader needed -- No decontamination requirements -- No false positives -- No false negatives -- No hook effect "We are very proud to be providing our detection equipment for protection of the capitol," said Mr. Jacques Tizabi, UNDT`s Chief Executive Officer. "This is the second order from the FEMS and it is a testament to the quality and accuracy of our equipment," he added. About Universal Detection Technology Universal Detection Technology is a developer of monitoring technologies, including bioterrorism detection devices. The Company on its own and with development partners is positioned to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA, has developed a bacterial spore detector that detects certain biohazard substances. The Company is also a reseller of handheld assays used for detection of five bioterrorism agents, radiation detection systems, and antimicrobial products. ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ URRE Uranium Resources, Inc. Finance Uranium Resources, Inc. explores for, develops and mines uranium. Since its incorporation in 1977, URI has produced over 7 million pounds of uranium by in-situ recovery (ISR) methods in the state of Texas where the Company currently has ISR mining projects. URI also has 183,000 acres of uranium mineral holdings and 100 million pounds of uranium in New Mexico. The Company acquired these properties over the past 20 years along with an extensive information database. URI`s strategy is to capitalize on the strong global market for uranium by fully exploiting its resource base in Texas and New Mexico, acquiring new assets and through joint ventures or partnerships. ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ Today`s News GNBT Generex Biotechnology Corp. GNBT Website Finance Dec 16, 2008 -- Generex Biotechnology Corporation (Nasdaq:GNBT) and Pevion Biotech Ltd. (www.pevion.com) have signed an agreement to work together to develop next-generation vaccines and immunotherapeutic products. The initial goal of the collaboration will be to investigate synergies in the cancer vaccine approaches of the two companies. Both companies have in-depth experience in developing immunotherapeutic vaccines for cancers. A specific focus is oncogenes over-expressed in breast, ovarian, prostate, stomach and colon cancer, as well as a variety of other malignancies. Within this collaboration, Generex wholly-owned immunotherapy subsidiary Antigen Express, Inc. combines Pevion Biotech`s virosome technology with its own technology and is conducting trials in patients with breast, prostate and ovarian cancer. The combination of the two technologies will stimulate different portions of the immune system. Pevion Biotech has developed products based upon its virosome technology to enhance the vaccine potency of various antigens. Antigen Express is developing next-generation immunotherapeutic peptides using technology to increase antigen-specific stimulation of CD4+ T helper cells. T helper cells are known to play an important role in regulating many branches of the immune system (e.g., cellular and antibody responses) and have been characterized as the `generals` of the immune system. Virosomes are designed to interact with cells to elicit a robust immune response, as well as to deliver antigens for specific immune recognition. "We are very pleased to be collaborating with Pevion in the development of next-generation immunotherapeutic vaccines," said Dr. Eric von Hofe, President of Antigen Express. "Virosomes have clearly shown their potential now that there are two marketed products available currently." Rinaldo Zurbriggen, CSO of Pevion, commented: "This is a great opportunity to collaborate with qualified and experienced partners in the cancer field to advance their antigens as a potential next-generation immunotherapeutic approach for the treatment of cancer." About Pevion Biotech Pevion Biotech is a privately owned Swiss biopharmaceutical company focusing on the preclinical and clinical development of vaccines to prevent/treat infectious diseases and cancer. For its vaccine development, the company uses its virosome technology, which is already validated by two registered and marketed vaccines. The combination of this virosome technology with novel innovative antigens substantially reduces the known risk in biotechnological development and permits the targeting of diseases where so far no appropriate treatment is available. Pevion Biotech targets indications which represent major medical needs, including prophylactic or therapeutic vaccines against breast cancer, candidiasis, RSV and hepatitis C. Three virosome-based vaccine candidates are currently in clinical development. About Generex Biotechnology Corporation Generex is engaged in the research, development and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company`s proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company`s proprietary RapidMist(tm) device. The Company`s flagship product, oral insulin (Generex Oral-lyn(tm)), which is available for sale in India and Ecuador for the treatment of subjects with Type-1 and Type-2 diabetes, is in Phase III clinical trials at several sites around the world. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutics for the treatment of malignant, infectious, allergic, and autoimmune diseases. ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ Today`s News ALIN All Line, Inc. ALIN New Light Website Finance Dec 15, 2008 -- All Line, Inc., (PINKSHEETS: ALIN), a company engaged in telecommunications, multimedia, and IT development today announced that on December 12, 2008 the Company signed a definitive agreement to acquire a ten percent ownership in Chinese Media Group Corporation (CMGC), a company focused on providing multi-media contents to overseas Chinese, which has the potential to reach an enterprise value of more than $300 million in the next three to five years. According to the agreement, All Line agrees to pay CMGC $1,000,000 in cash and 15,000,000 shares of All Line restricted stock for the initial 10% stake in CMGC. The transaction is scheduled to close on or before February 13, 2009. All Line also has an option to acquire another 41% of CMGC in the future on terms and conditions mutually acceptable to both parties. The acquisition of CMGC is part of All Line`s new initiative to own interests in select Asian multi-media businesses that have potential for sustainable growth with a goal to eventually consolidate highly successful ones under a new All Line`s Asian multimedia division in the future. Allen Wu, Chairman of East Media Holdings (EMHI) which owns the majority of CMGC, stated: "With Chinese Americans representing the largest Asian-American group in the U.S., one and half billion Chinese-speaking population in Greater China and throughout ASEAN and beyond, we expect to witness exciting developments going forward and the potential to reach an enterprise value of $300 million or more for CMGC in the next three to five years." Won Jai Chang, President of All Line, concurred: "We are very excited about the definitive agreement with Chinese Media Group. This fits well with All Line`s new initiative to own interests in select Asian multi-media businesses that have potential for high growth and we believe this will increase the market value of our company." About All Line All Line, Inc. is a Nevada corporation engaged in telecommunication, multimedia, IT development, and environmentally friendly energy and resources. The Company has established strong business ties in these areas with Korea and other Asian countries. ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ Today`s News LVLT Level 3 Communications, Inc. LVLT Website Finance Dec 16, 2008 -- Level 3 Communications, Inc. (Nasdaq: LVLT) announced today that it has reduced the minimum tender condition for each of its three previously announced tender offers to purchase for cash any and all of its outstanding convertible notes listed in the table below. In addition, Level 3 announced that the expiration date for each tender offer has been extended to 12:00 midnight, New York City time, on December 22, 2008. Each tender offer remains subject to all other terms and conditions set forth in the Offer to Purchase dated November 17, 2008. Level 3`s obligation to accept for payment, and to pay for, any notes in a series validly tendered pursuant to a tender offer is now subject to, among other things, there being validly tendered and not validly withdrawn on or prior to December 22, 2008 at least such principal amount of notes in that series set forth in the table below under "Revised Minimum Tender Condition." Outstanding Revised Minimum Title of Security Principal Amount Tender Condition 2.875% Convertible Senior Notes due 2010 $354,541,000 $162,000,000 6% Convertible Subordinated Notes due 2010 $481,666,000 $173,000,000 6% Convertible Subordinated Notes due 2009 $305,135,000 $135,000,000 In addition, (a) the tender offer to purchase its 6% Convertible Subordinated Notes due 2009 is conditioned on the acceptance for payment by Level 3 of both its 2.875% Convertible Senior Notes due 2010 and its 6% Convertible Subordinated Notes 2010 pursuant to the terms and conditions of such other applicable tender offers, (b) the tender offer to purchase its 6% Convertible Subordinated Notes 2010 is conditioned on the acceptance for payment by Level 3 of its 2.875% Convertible Senior Notes due 2010 pursuant to the terms and conditions of the tender offer for those 2.875% Convertible Senior Notes due 2010 and (c) the tender offer to purchase its 2.875% Convertible Senior Notes due 2010 is conditioned on the acceptance for payment by Level 3 of its 6% Convertible Subordinated Notes 2010 pursuant to the terms and conditions of the tender offer for those 6% Convertible Subordinated Notes 2010. Each tender offer commenced on November 17, 2008, and is now scheduled to expire at 12:00 midnight, New York City time, on December 22, 2008, unless further extended for that tender offer as described in the Offer to Purchase. As announced previously, Level 3 intends to fund purchases of the notes from the net proceeds of the sale of Level 3`s to be newly issued 15% Convertible Subordinated Notes due 2013 and from cash on hand. Level 3 also announced today that it is amending the securities purchase agreement relating to the sale of its 15% Convertible Subordinated Notes due 2013. The amendment will reduce, to $162,000,000 and $173,000,000, respectively, the minimum aggregate principal amount of 2.875% Convertible Senior Notes due 2010 and 6% Convertible Subordinated Notes due 2010 that must be accepted for payment in the tender offers for those notes as a condition to closing the offering of the 15% Convertible Subordinated Notes due 2013. As of the close of business on December 15, 2008, an aggregate of $163,760,000 principal amount of Level 3`s 2.875% Convertible Senior Notes due 2010, $174,417,000 principal amount of Level 3`s 6% Convertible Subordinated Notes due 2010 and $137,464,000 principal amount of Level 3`s 6% Convertible Subordinated Notes due 2009 have been validly tendered in the applicable tender offers for such notes. As announced previously, Level 3 has waived the financing condition to the tender offers that Level 3 shall have sold at least $373 million aggregate principal amount of its 15% Convertible Senior Notes due 2013. The complete terms and conditions of each offer are set forth in the Offer to Purchase that was sent to holders of the notes and is also available online on the SEC`s website at www.sec.gov. Holders are urged to read the tender offer documents carefully. Copies of the Offer to Purchase and the related Letter of Transmittal may be obtained from the Information Agent for the offers, Global Bondholder Services Corporation, at (866) 389-1500 (toll-free). Citi and Merrill Lynch & Co. are the dealer managers for the offers. Questions regarding the offers may be directed to Citi at (800) 558-3745 (toll-free) and (212) 723-6106 or Merrill Lynch at (888) 654-8637 (toll-free) and (212) 449-4914. About Level 3 Communications Level 3 Communications, Inc. (NASDAQ: LVLT) is a leading international provider of fiber-based communications services. Enterprise, content, wholesale and government customers rely on Level 3 to deliver services with an industry-leading combination of scalability and quality, over an end-to-end fiber network. Level 3 offers a portfolio of metro and long-haul services over an end-to-end fiber network, including transport, data, internet, content delivery and voice. Level 3 Communications, Level 3, the red 3D brackets and the Level 3 Communications logo are registered service marks of Level 3 Communications, LLC and/or its affiliates in the United States and/or other countries. Level 3 services are provided by wholly owned subsidiaries of Level 3 Communications, Inc. Any other service, product or company names recited herein are trademarks or service marks of their respective owners. ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ SVMI SaVi Media Group, Inc. SVMI Website Finance Savi Media Group, Inc. creates and commercializes the world`s best blow-by gas and crankcase engine emission reduction technology. They have created the World`s first truly simple gasoline and diesel engine emission reduction technology and it allows them to provide their clients a lower-cost and more effective and efficient emission reduction and engine efficiency (leading to better mileage and lifespan) solutions - NOW. Savi Media Group, Inc. is the evolution of more than twenty man-years of emissions and materials R&D work. The Company was formed to create, support and license a patented supplementary vehicle emissions reduction and fuel efficiency technology that can reduce emissions and improve efficiency. Using proprietary methods and processes SAVI increases fuel efficiency at the same time decreases emissions and extends component life. The SAVI core CVS technology allows for dramatic reductions in harmful emissions in engines and vehicles, a significant reduction in costs to do so as well as reducing all related emission costs. The end result is delivering superior emission reduction technology and operating performance. ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ These "Green Play`s" are something that us here at Standout Stocks feel we should bring to the attention of all investors. These "Green Play`s" are not only beneficial for the investors but they benefit us all by producing "Environment Friendly" products and Alternative "Natural" Energy Sources. So you can see why these Green Play`s are worth the time to take a look at. Remember these "Green Play`s" are definatly companies worth keeping an eye on to watch for the "Pop"! Standout Stock`s goal is to bring to you accurate, up-to-date news in a timely fashion. Standout Stocks has continuously been bringing you the biggest movers and shakers in the Small Cap and Micro Cap markets. Spread the word! We would like to say "Thank You" to all of our subscribers and "Welcome" to our newest members! To ensure delivery of this service, please add mail@newmediaadvisorsllc.com to your e-mail address book Sincerely, The Standout Stocks Team! In This Issue UNDT URRE GNBT ALIN LVLT SVMI ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ Quick Links StandoutStocks.com PennyPerformers.com Disclaimer NewMediaAdvisorsllc.com ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ ~~~~~~~~~~~~~~~~~~~~~~~~~~ FREE Stock Alerts By Email! About New Media Advisors The emphasis of our company is on increasing investor awareness, share volume and share value. We are confident that these topics are cretainly of interest to you. Our concentration is in the area of working with emerging small and microcap companies. For support, we have two award winning sites that we utilize to help bring exposure to your company (Penny Performers and Standout Stocks). Disclaimer: http://www.newmediaadvisorsllc.com/disclaimer.aspx See Standout Stocks's website for full disclaimer. Standout Stocks may have received compensation for stock picks. |
